scholarly journals Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients

Vaccine ◽  
2021 ◽  
Vol 39 (1) ◽  
pp. 6-10
Author(s):  
Josephine Ocran-Appiah ◽  
Céline Boutry ◽  
Caroline Hervé ◽  
Jyoti Soni ◽  
Anne Schuind
Keyword(s):  
Zoster Vaccine ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iiib ◽  
Recombinant Zoster Vaccine ◽  
Placebo Recipients

scholarly journals Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

2019 ◽  
Vol 30 ◽  
pp. ix161-ix162
Author(s):  
F. De Marinis ◽  
K.K. Laktionov ◽  
A. Poltoratskiy ◽  
I. Egorova ◽  
M. Hochmair ◽  
...  
Keyword(s):  
Interim Analysis ◽  
Egfr Mutation ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iiib ◽  
Egfr Tki

EP1.14-49 A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Exploratory Biomarker Analysis

2019 ◽  
Vol 14 (10) ◽  
pp. S1050-S1051
Author(s):  
J. Wang ◽  
J. Zhao ◽  
H. Bai ◽  
X. Wang ◽  
Y. Wang ◽  
...  
Keyword(s):  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Biomarker Analysis ◽  
Phase Iiib ◽  
Egfr Tki

scholarly journals P2.14-58 A Phase IIIb, Open-Label Study of Afatinib in Caucasian EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis

2019 ◽  
Vol 14 (10) ◽  
pp. S853-S854
Author(s):  
F. De Marinis ◽  
K.K. Laktionov ◽  
A. Poltoratskiy ◽  
I. Egorova ◽  
M.J. Hochmair ◽  
...  
Keyword(s):  
Interim Analysis ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iiib ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document